A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
318 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Alexander Fleming
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Recruiting - Local Institution - 0568
Lujan de Cuyo, Mendoza Province, Argentina
Not, yet, recruiting - Local Institution - 0463
Rosario, Santa Fe Province, Argentina
Not, yet, recruiting - Local Institution - 0618
Rosario, Santa Fe Province, Argentina
Not, yet, recruiting - Centro Oncologico Korben
Buenos Aires, Argentina
Recruiting - Local Institution - 0446
Buenos Aires, Argentina
Not, yet, recruiting - Local Institution - 0472
Buenos Aires, Argentina
Not, yet, recruiting
- Local Institution - 0432
Liverpool, New South Wales, Australia
Not, yet, recruiting - Local Institution - 0591
St Leonards, New South Wales, Australia
Not, yet, recruiting - Sunshine Coast University Hospital
Birtinya, Queensland, Australia
Recruiting - Princess Alexandra Hospital
Brisbane, Queensland, Australia
Recruiting - Lyell Mcewin Hospital
Elizabeth Vale, South Australia, Australia
Recruiting - Royal Hobart Hospital
Hobart, Tasmania, Australia
Recruiting - Grampians Health
Ballarat Central, Victoria, Australia
Recruiting - Local Institution - 0368
Garran, Australia
Not, yet, recruiting
- Ordensklinikum Linz Gmbh Elisabethinen
Linz, Upper Austria, Austria
Recruiting - Landeskrankenhaus Rankweil
Rankweil, Austria
Recruiting - Klinik Floridsdorf
Vienna, Austria
Recruiting
- Antwerp University Hospital
Edegem, Antwerpen, Belgium
Recruiting - Local Institution - 0225
Yvoir, Namur, Belgium
Not, yet, recruiting - Az Delta Vzw
Roeselare, West-Vlaanderen, Belgium
Recruiting - Uz Brussel
Brussels, Belgium
Recruiting - Local Institution - 0340
Liège, Belgium
Not, yet, recruiting
- Local Institution - 0077
Fortaleza, Ceará, Brazil
Not, yet, recruiting - Cedoes
Vitória, Espírito Santo, Brazil
Recruiting - Local Institution - 0576
Porto Alegre, Rio Grande Do Sil, Brazil
Not, yet, recruiting - Liga Norte Riograndense Contra O Câncer
Natal, Rio Grande do Norte, Brazil
Recruiting - Hospital Nossa Senhora Da Conceição
Porto Alegre, Rio Grande do Sul, Brazil
Recruiting - Local Institution - 0080
Santa Cruz do Sul, Rio Grande do Sul, Brazil
Not, yet, recruiting - Clínica de Oncologia Reichow
Blumenau, Santa Catarina, Brazil
Recruiting - Fundação Pio Xii - Hospital de Câncer de Barretos
Barretos, São Paulo, Brazil
Recruiting - Naic - Instituto Do Câncer
Bauru, São Paulo, Brazil
Recruiting - Centro de Pesquisa Sao Lucas
Campinas, São Paulo, Brazil
Recruiting - Local Institution - 0355
São Caetano do Sul, São Paulo, Brazil
Not, yet, recruiting - Fundação Faculdade Regional de Medicina de São José Do Rio Preto
São José do Rio Preto, São Paulo, Brazil
Recruiting - A. C. Camargo Cancer Center
São Paulo, São Paulo, Brazil
Recruiting - Instituto Nacional de Câncer - Inca
Rio de Janeiro, Brazil
Recruiting - Icesp - Instituto Do Câncer Do Estado de São Paulo
São Paulo, Brazil
Recruiting
- Local Institution - 0315
Panagyurishte, Pazardzhik, Bulgaria
Withdrawn - Specialized Hospital for Active Treatment of Oncology - Haskovo
Haskovo, Bulgaria
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Jan 2026
- Primary completion
- 12 Aug 2031
- Completion
- 12 Aug 2031
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 590
- Registry id
- NCT07063745
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.